Livongo Health, the diabetes management startup launched last year by former Allscripts CEO Glen Tullman, will roll out its platform to a large group of New Yorkers via the Mount Sinai health system.

Chronic disease management startup Livongo announced a handful of new offerings and partnerships this week, all organized around the theme of “Applied Health Signals,” a framework for thinking about ...

Telehealth company Teladoc Health has launched an A1C at-home diabetes testing program for members of its Livongo diabetes management program. A1C tests determine blood sugar levels and are used to ...

Livongo Health said that its Diabetes Prevention Program has received full recognition from the Centers for Disease Control and Prevention. The accolade means the program has met CDC standards and can ...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Livongo Health, the leading consumer digital health company focused on chronic conditions, announced the completion of a $44.5 million Series C financing round.

Livongo, a Mountain View, Calif.-based digital health platform for chronic disease management, signed an agreement to provide its diabetes management program to eligible members of the Federal ...

Second quarter Total Revenue of $40.9 million, up 156% year-over-year 192,934 enrolled Livongo for Diabetes Members, up 140% year-over-year with 38,170 new Livongo for Diabetes Members in Q2 MOUNTAIN ...

Teladoc's share price has ranged between $22 and $294 since the pandemic. Management deserves blame for poorly navigating the Livongo deal. The company's prospects make a long-term rebound possible.

Over 422 million people around the world have diabetes, with the World Health Organization noting that the majority of those with the disease are living in low-income and middle-income countries. “In ...